Literature DB >> 8051562

Cerebrospinal fluid nitrite/nitrate levels in neurologic diseases.

S Milstien1, N Sakai, B J Brew, C Krieger, J H Vickers, K Saito, M P Heyes.   

Abstract

Nitric oxide has been proposed to mediate cytotoxic effects in inflammatory diseases. To investigate the possibility that overproduction of nitric oxide might play a role in the neuropathology of inflammatory and noninflammatory neurological diseases, we compared levels of the markers of nitric oxide, nitrite plus nitrate, in the CSF of controls with those in patients with various neurologic diseases, including Huntington's and Alzheimer's disease, amyotrophic lateral sclerosis, and HIV infection. We found that there were no significant increases in the CSF levels of these nitric oxide metabolites, even in patients infected with HIV or in monkeys infected with poliovirus, both of which have significantly elevated levels of the neurotoxin quinolinic acid and the marker of macrophage activation, neopterin. However, CSF quinolinic acid, neopterin, and nitrite/nitrate levels were significantly increased in a small group of patients with bacterial and viral meningitis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8051562     DOI: 10.1046/j.1471-4159.1994.63031178.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  13 in total

1.  Expression of inflammatory cytokines and inducible nitric oxide synthase in brains of SIV-infected rhesus monkeys: applications to HIV-induced central nervous system disease.

Authors:  T E Lane; M J Buchmeier; D D Watry; H S Fox
Journal:  Mol Med       Date:  1996-01       Impact factor: 6.354

2.  No changes in cerebrospinal fluid levels of nitrite, nitrate and cyclic GMP with aging. Short communication.

Authors:  K Yamada; K Nishiwaki; K Hattori; K Senzaki; M Nagata; T Komatsu; Y Shimada; T Nabeshima
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

3.  Nitrite, nitrate and cGMP in the cerebrospinal fluid in degenerative neurologic diseases.

Authors:  M Ikeda; I Sato; T Yuasa; T Miyatake; S Murota
Journal:  J Neural Transm Gen Sect       Date:  1995

4.  A rostrocaudal gradient of nitrate plus nitrite concentrations in CSF.

Authors:  R Surtees; S Heales
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-01       Impact factor: 10.154

Review 5.  The role of nitric oxide in neurodegeneration. Potential for pharmacological intervention.

Authors:  J A Molina; F J Jiménez-Jiménez; M Ortí-Pareja; J A Navarro
Journal:  Drugs Aging       Date:  1998-04       Impact factor: 3.923

6.  Human microglia convert l-tryptophan into the neurotoxin quinolinic acid.

Authors:  M P Heyes; C L Achim; C A Wiley; E O Major; K Saito; S P Markey
Journal:  Biochem J       Date:  1996-12-01       Impact factor: 3.857

7.  Increased quinolinic acid in peripheral mononuclear cells in Alzheimer's dementia.

Authors:  Mandy Busse; Vanessa Hettler; Victoria Fischer; Christian Mawrin; Roland Hartig; Henrik Dobrowolny; Bernhard Bogerts; Thomas Frodl; Stefan Busse
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-04-06       Impact factor: 5.270

8.  Potential role of nitric oxide in the pathophysiology of experimental bacterial meningitis in rats.

Authors:  B L Buster; A C Weintrob; G C Townsend; W M Scheld
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

9.  Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation.

Authors:  K Hensley; M L Maidt; Z Yu; H Sang; W R Markesbery; R A Floyd
Journal:  J Neurosci       Date:  1998-10-15       Impact factor: 6.167

10.  Mechanism of inducible nitric-oxide synthase dimerization inhibition by novel pyrimidine imidazoles.

Authors:  Latika Nagpal; Mohammad M Haque; Amit Saha; Nirmalya Mukherjee; Arnab Ghosh; Brindaban C Ranu; Dennis J Stuehr; Koustubh Panda
Journal:  J Biol Chem       Date:  2013-05-21       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.